Griseofulvin 00781-5514
Product NDC
00781-5514- Manufacturer
- Sandoz Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 7, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA091592
Need to source Griseofulvin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Griseofulvin | 250 mg/1 |
Drug Class
Tubulin Inhibiting Agent [EPC]Decreased Mitosis [PE]Microtubule Inhibition [PE]
Packaging Options(2)
100 TABLET in 1 BOTTLE (0781-5514-01)
500 TABLET in 1 BOTTLE (0781-5514-05)